Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Intact Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Intact Therapeutics

Intact Therapeutics

Series A

Intact Therapeutics: Innovating gut-targeted drug delivery with smart gels.

HQ
Belmont, CA, US
Founded
2015
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize drug delivery for gastrointestinal disorders, Intact Therapeutics focuses on creating advanced materials that enhance the absorption and efficacy of medications in the digestive tract. Their core product, smart gels, is designed to provide localized drug delivery, addressing a range of currently underserved gastrointestinal conditions. This innovative approach aims to improve patient outcomes by ensuring that medications are more effectively delivered and absorbed where they are needed most.

Intact Therapeutics has garnered attention from notable partners and investors in the healthcare and biotech sectors, reflecting confidence in their groundbreaking technology. The company has achieved significant milestones in developing their smart gel platform, positioning themselves as a leader in gut-targeted drug delivery solutions. Their work has the potential to significantly impact the treatment landscape for gastrointestinal disorders, offering new hope and improved quality of life for patients worldwide.

Intact Therapeutics - Similar Companies

Edulis Therapeutics logo

Edulis Therapeutics

edulis.xyz

Eugit Therapeutics logo

Eugit Therapeutics

eugittx.com

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Gel4Med logo

Gel4Med

gelformed.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Equator Therapeutics logo

Equator Therapeutics

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

Petri Bio logo

Petri Bio

petribio.com

Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Syntis Bio logo

Syntis Bio

syntis.bio

Intellimedix logo

Intellimedix

Entrada Therapeutics logo

Entrada Therapeutics

entradatx.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Enterin logo

Enterin

enterininc.com

Invea Therapeutics logo

Invea Therapeutics

inveatx.com

Intact Therapeutics - Quick Facts

Who are Intact Therapeutics' competitors?

Companies similar to Intact Therapeutics include Edulis Therapeutics, Eugit Therapeutics, i2o Therapeutics and Gel4Med.

When was Intact Therapeutics founded?

Intact Therapeutics was founded in 2015.

Where is Intact Therapeutics' headquarters located?

Intact Therapeutics' headquarters is located in Belmont, CA, US.

When was Intact Therapeutics' last funding round?

Intact Therapeutics' most recent funding round was for $250k (USD) in November 2021.

How much has Intact Therapeutics raised to-date?

As of Nov 17, 2021, Intact Therapeutics has raised a total of $645k (USD).

How many employees does Intact Therapeutics have?

Intact Therapeutics has 3 employees as of Feb 4, 2024.

Intact Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research